AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163U956. A total of 4 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $106,000 | -83.1% | 113 | -86.2% | 0.00% | -100.0% |
Q2 2020 | $626,000 | +1260.9% | 819 | +977.6% | 0.00% | – |
Q1 2020 | $46,000 | -73.9% | 76 | -47.6% | 0.00% | – |
Q4 2019 | $176,000 | -39.1% | 145 | -42.2% | 0.00% | -100.0% |
Q3 2019 | $289,000 | -28.1% | 251 | -37.7% | 0.00% | 0.0% |
Q2 2019 | $402,000 | -3.4% | 403 | +24.8% | 0.00% | 0.0% |
Q1 2019 | $416,000 | +13766.7% | 323 | +16050.0% | 0.00% | – |
Q4 2018 | $3,000 | -96.7% | 2 | -95.7% | 0.00% | – |
Q3 2018 | $92,000 | +100.0% | 46 | +91.7% | 0.00% | – |
Q2 2018 | $46,000 | +228.6% | 24 | -89.3% | 0.00% | -100.0% |
Q1 2018 | $14,000 | -97.0% | 225 | -74.2% | 0.00% | -95.0% |
Q4 2017 | $472,000 | +948.9% | 871 | +151.0% | 0.02% | +900.0% |
Q3 2017 | $45,000 | -13.5% | 347 | +5.2% | 0.00% | 0.0% |
Q2 2017 | $52,000 | +477.8% | 330 | +1334.8% | 0.00% | – |
Q1 2017 | $9,000 | -25.0% | 23 | -89.2% | 0.00% | -100.0% |
Q4 2016 | $12,000 | -81.8% | 213 | -61.3% | 0.00% | -75.0% |
Q3 2016 | $66,000 | -35.3% | 551 | -3.5% | 0.00% | -42.9% |
Q2 2016 | $102,000 | +628.6% | 571 | +507.4% | 0.01% | +600.0% |
Q1 2016 | $14,000 | -86.7% | 94 | +77.4% | 0.00% | -87.5% |
Q4 2015 | $105,000 | -21.6% | 53 | -35.4% | 0.01% | -20.0% |
Q3 2015 | $134,000 | +688.2% | 82 | +1.2% | 0.01% | +900.0% |
Q2 2015 | $17,000 | -50.0% | 81 | -5.8% | 0.00% | -75.0% |
Q1 2015 | $34,000 | +3300.0% | 86 | +160.6% | 0.00% | – |
Q4 2014 | $1,000 | – | 33 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 207,000 | $62,000 | 0.06% |
JPMORGAN CHASE & CO | 7,454,070 | $182,699,000 | 0.04% |
SIMPLEX TRADING, LLC | 551 | $66,000 | 0.00% |
GROUP ONE TRADING, L.P. | 2,100 | $51,000 | 0.00% |